You just read:

Morphotek And Rockefeller University Form A Sponsored Research Agreement To Study The Immunosuppressive Effects Of The Tumor Shed Antigen CA125 And Its Potential Impact In Future Patient Therapies

News provided by

Morphotek, Inc.

Dec 11, 2017, 09:00 ET